Purpose

Whilst it is known that oxidative stress can cause early degenerative changes observed in experimental osteoarthritis and that a major drawback of current cartilage and intervertebral disc tissue engineering is that human mesenchymal stem cells (MSCs) from osteoarthritis (OA) patients express type X collagen, a marker of late-stage chondrocyte hypertrophy (associated with endochondral ossification), little is known whether the expression of type X collagen in MSCs from OA patients can be related to oxidative stress or inflammatory reactions that occur during this disease.

Purpose: Several studies have been directed toward using mesenchymal stem cells (MSCs) from osteoarthritic (OA) patients for cartilage or disc repair because these patients are the ones that will require a source of autologous stem cells if biological repair of tissue lesions is to be a therapeutic option. A major drawback of current cartilage and intervertebral disc tissue engineering repair is that these cells rapidly express type X collagen, a marker of late stage chondrocyte hyperthrophy implicated in endochondral ossification. However, a novel plasma-polymerized thin film material, named nitrogen-rich plasma-polymerized ethylene (PPE:N), is able to inhibit type X collagen expression in committed MSCs. The specific aim of this study was to determine if the suppression of type X collagen by PPE:N is maintained when MSCs are transferred to pellet cultures in chondrogenic defined media.

Method: MSCs were obtained from aspirates from the intramedullary canal of donors undergoing total hip replacement for OA using a protocol approved by the Research Ethics Committee of our institution. Cells were then expanded for 2–3 passages in DMEM high glucose supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin, and finally cultured on polystyrene (PS) cell culture dishes or PPE: N surfaces for 3 and 7 days. Cells were transferred for 3 additional days in a chondrogenic serum free media (DMEM high glucose supplemented with 2 mM L-glutamine, 20 mM HEPES, 45 mM NaHCO3, 100 U/ml penicillin, 100 μg/ml streptomycin, 1 mg/ml bovine serum albumin, 5 μg/ml insulin, 50 μg/ml ascorbic acid, 5 ng/ ml sodium selenite, 5 μg/ml transferrin) in pellet culture or on PS cell culture dishes. Cells were then lysed and proteins were separated on 4–20% acrylamide gels and transferred to nitrocellulose membranes. Type X collagen was detected by Western blot; GAPDH expression was used as an internal control for protein loading.

Results: Results showed that type X collagen protein was expressed in MSCs from OA patients cultured on polystyrene but was suppressed when cultured on PPE: N. Since defined chondrogenic medium are commonly used in pellet culture to promote in vitro chondrogenesis, we then investigated the effect of transferring cells pre-cultured on PPE:N into pellet culture on type X collagen expression. However, the decreased type X collagen expression was not maintained in these conditions and that the expression returned to control values. The decreased type X collagen expression was maintained when the cells were cultured on PS cell culture dishes.

Conclusion: The use of MSCs is promising for tissue engineering of cartilage and intervertebral disc. The present study confirmed the potential of PPE:N surfaces in suppressing type X collagen expression in MSCs from OA patients. However, when MSCs stem cells are transferred to pellet cultures, type X collagen is rapidly re-expressed suggesting that pellet cultures may not be suitable for chondrogenesis of MSCs from OA patients.

Purpose: Mesenchymal stem cells (MSCs) from osteoarthritic (OA) patients are not well characterized and little is known of how they are regulated. Recent evidence indicates that a major drawback of current cartilage and intervertebral disc (IVD) tissue engineering is that human MSCs from OA patients express type X collagen (COL10), a marker of late-stage chondrocyte hypertrophy (associated with endochondral ossification). However, the intracellular pathways for transducing signals that regulate hypertrophy in MSCs remain unclear. In chondrocytes, this pathway is mediated by mitogen activated protein kinase (MAPK) p38. The aim of this study was to determine the phosphorylation levels of ERK/p38 MAPK signaling molecules in MSCs from OA patients compared to those from normal patients.

Method: MSCs were obtained from aspirates from the intramedullary canal of donors (60–80 years of age) undergoing total hip replacement for OA. Cells were cultured in DMEM high glucose supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin for 2–3 passages. Cells were then lysed and proteins were separated on 10% acrylamide gels and transferred to nitrocellulose membranes. Protein expression was determined by Western blot using specific antibodies directed against type X collagen, ERK, phosphorylated-ERK, p38, phosphorylated-p38, JNK, phosphorylated-JNK, AKT, and phosphorylated-AKT. GAPDH was used as a housekeeping gene. Proteins were detected using the West Pico Chemiluminescence substrates and analyzed using the Bio-Rad VersaDoc equipped with a cooled CCD 12 bit camera. Normal mesenchymal stem cells from a 22 years old woman were purchased from Lonza (Switzerland).

Results: Results show that the expression of COL10 was markedly increased in MSCs of OA patients compared to control patient. Results also shows that the phosphorylation of all the signal transduction proteins studied was induced in MSCs of patients with OA. Indeed, the phosphorylation of ERK (3.4±0.9 times the control), p38 (1.7±0.3 times the control), JNK (5.40±1.14 times the control), and AKT (4.3±0.8 times the control) was higher in MSCs of OA patients compared to control normal patients.

Conclusion: In the normal donor, MSCs continue to exhibit their in situ behavior in that they expressed very little or no COL10. This may relate to the fact that normal MSCs being multipotent in nature like to maintain an undifferentiated state. In contrast, MSCs from OA patients expressed COL10: this suggests that they are in a situation were they can be preprogrammed not only to replace the degraded articular cartilage but also the damaged subchondral bone. Since the phosphorylation of ERK/p38 MAPK signaling molecules is also lower in normal MSCs, our results also suggest that this signaling pathway is implicated in the control of COL10 expression. This finding is of great importance for the understanding of COL10 regulation in general and may lead to important advances in the comprehension of COL10 related diseases.

Purpose: A major drawback of current cartilage and intervertebral disc tissue engineering is that human mesenchymal stem cells (MSCs) from osteoarthritis (OA) patients express type X collagen (COL10), a marker of late-stage chondrocyte hypertrophy (associated with endochondral ossification). Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) regulate endochondral ossification by inhibiting chondrocyte differentiation toward hypertrophy. In the present study, we investigated the effect of PTH on the expression of COL10 in MSCs from OA patients and analyzed the potential mechanisms related to its effect.

Method: MSCs were obtained from aspirates from the intramedullary canal of donors (60–80 years of age) undergoing total hip replacement for OA. Cells were cultured for 2–3 passages in DMEM high glucose supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. Cells were then incubated for 0–24h without (Control) or with 100 nM PTH (1–34). Cells were lysed and proteins were separated on 10% acrylamide gels and transferred to nitrocellulose membranes. Protein expression was detected by Western blot using specific antibodies directed against COL10, p38, phosphorylated-p38 (p-p38), SAP/JNK, phosphorylated-SAP/JNK (p-JUNK). GAPDH was used as a housekeeping gene. Protein levels were analyzed using a Bio-Rad VersaDoc equipped with a cooled CCD 12 bit camera.

Results: Results showed that PTH inhibited in a time-dependent manner the expression of COL10 in MSCs from OA patients. The level of expression reached 21% of control (79% inhibition) after 24h. This inhibitory effect of PTH was reversed by Calphostin C, an inhibitor of protein kinase C. To further investigate the mechanism of action related to the effect of PTH on COL10 expression, we measured the phosphorylation of p38 and showed that PTH also inhibited this phosphorylation, which is an indicator of its activity. The level of phosphorylation reached 74% of control after 3h and stayed stable thereafter. Similarly, treatment of MSCs with PTH suppressed the phosphorylation of JNK, another major stress-activated MAP kinase. The level of phosphorylation reached 65% of control after 6h and returned to control values after 24h.

Conclusion: Results of the present study suggested that PTH may be a potential regulator of COL10 expression in MSCs from OA patients. Results also suggested a role for the protein kinase C and the p38/JNK pathways in this regulation. p38 and JNK are serine and threonine protein kinases that are activated by osmotic pressure, stress, and cytokines. It is therefore not surprising that their activities were elevated as OA (degenerative joint disease) is a result of trauma or infection to the joint and is characterized by an up-regulation of cytokines. Further studies are however necessary to better understand the role of these molecules in hypertrophy.

Spinal fusion surgery is a common procedure for the treatment of various spinal diseases. Several growth factors, including bone morphogenic protein-2 (BMP-2) and osteogenic protein-1 (OP-1) have been used in spinal fusion for the induction of bone formation. But complications have been reported due to the lack of suitable carrier. Here we hypothesis that Insoluble Bone Gelatin (ISBG) may be a good carrier for OP-1 in the induction of bone formation during spinal fusion. The aim of this study is to examine the efficacy of osteoconductive carrier, ISBG, for OP-1 in rabbit lumbar inter-transverse process fusion model.

Adult New Zealand White rabbits (n=32) underwent bilateral lumbar intertransverse process fusion at L5-L6. The animals were divided into four groups based on the materials implanted:

Autograft group,

Spinal fusion masses were evaluated by manual palpation, biomechanical testing, radiographic examination, micro-CT Scanning, and histological analysis six weeks after surgery.

ISBG+OP-1 group demonstrated significantly higher fusion rates (7/7) than autograft (3/7), ISBG (2/8), and OP-1 groups (2/7) (P< 0.05) based on manual palpation. In biomechanical testing, given the same moment, the fusion masses of ISBG+OP-1 group had less range of motions than those of other groups (P< 0.05) in main direction motion. Radiographic examination and micro-CT demonstrated that continuous trabecular pattern within intertransverse process area in ISBG+OP-1 group than other groups, and radiographic scores and bone volume base on micro-CT were also higher than other groups. Mature new bone formation was observed covering the surface of transverse processes in all four groups in histological findings. Continuous trabeculae connected two transverse processes and endochondral bone formation was observed attached the surface of ISBG in ISBG+OP-1 group. However, in other three groups, obvious gaps were noted in fusion masses and fibrous tissue was filled in these gaps.

In conclusion, OP-1 carried by ISBG results in more effective spinal fusion in posterolateral lumbar transverse fusion in rabbit model than autograft, ISBG or OP-1 alone.